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Abstract: Nanoparticles based on cationic polymers, lipids or lipidoids are of great interest in 
the field of gene delivery applications. The research on these nanosystems is rapidly growing 
as they hold promise to treat wide variety of human diseases ranging from viral infections to 
genetic disorders and cancer. Recently, combinatorial design principles have been adopted for 
rapid generation of large numbers of chemically diverse polymers and lipids capable of 
forming multifunctional nanocarriers for the use in gene delivery applications. At the same 
time, current high-throughput screening systems as well as convenient cell assays and readout 
techniques allow for fast evaluation of cell transfection efficiencies and toxicities of libraries 
of novel gene delivery agents. This allows for a rapid evaluation of structure-function 
relationship as well as identification of novel efficient nanocarriers for cell transfection and 
gene therapy. This progress report describes the recent contribution of high-throughput 
synthesis to the development of novel nanocarriers for gene delivery applications.  
 
1. Introduction 
Gene therapy is of great interest to treat wide variety of human diseases ranging from 
viral infections[1] to genetic disorders[2] and cancer[3-5]. However, despite a lot of research the 
primary challenge in gene therapy is still to develop safe, non-toxic and efficient nucleic acid 
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delivery vectors. Gene delivery approaches can be divided into two categories: based on viral 
vectors[6,7] and non-viral/synthetic vectors[8-11]. Although most of the gene delivery 
therapeutics in clinical trials are based on viral vectors[12], safety concerns and manufacturing 
costs are the major concerns of this approach[13]. On the other hand, synthetic vectors offer 
greater flexibility, facile manufacturing and safer delivery platforms. Non-viral vectors 
include carriers based on small molecules covalently bound to nucleic acids[14-15], cationic 
lipids[16-18], cationic polymers[19-21] and antibody fusion proteins[22-23]. Direct conjugation of 
nucleic acid with the carrier has some limitations. It might affect the native property of the 
nucleic acid and lead to its faster degradation because of exposure to the extra- and intra-
cellular environment. Among all non-viral delivery approaches, cationic polymers and 
cationic lipid families are the most investigated classes of synthetic materials for nucleic acid 
delivery. Nanostructures such as liposomes, polymersomes and nanoparticles made of self-
assembled cationic lipids[24-29] and polymers[30-34] have been extensively used as delivery 
vehicles of genes and biopharmaceuticals (e.g. proteins, peptides). Cationic lipids or polymers 
electrostatically bind to negatively charged nucleic acids, condense them into nanosized 
particles, protect from the influence of extra-cellular environment and mediate cellular entry.  
Once the nanoparticle enters the cell, it has to escape from the endosome and release 
the nucleic acid into the cytoplasm. Depending on the type of nucleic acid, it has to target 
either cytoplasm or be transported into the nucleus. For example, siRNA molecules can knock 
down a gene by targeting complementary mRNA in the cytoplasm[35], while plasmid DNA 
has to be imported into the nucleus for gene expression to occur[36]. Due to these intriguing 
properties of cationic lipids and polymers, the current research has been focused on their 
custom-design, engineering and self-organization to nanostructures. In general, the gene 
delivery functionality of lipids or polymers is a result of their self-assembly into liposomes, 
polymersomes or lipoplexes and polyplexes after complexation with nucleic acids. The 
efficiency, toxicity, stability and many other properties of the produced nanocarriers depend 
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on the process of self-organization and both physical and chemical properties of the formed 
nanoparticles. Thus, the lipid- and polymer-based gene delivery vectors fall under the concept 
of nanoarchitectonics introduced several years ago[37-39].  
The mode of internalization of lipoplexes or polyplexes has an influence on the 
kinetics in their intracellular processing and transfection efficiency. Lipoplexes and 
polyplexes are believed to enter the cell through endocytic pathways. Endocytic pathways 
have been categorized into phagocytosis and pinocytosis[40]. Phagocytosis is restricted to 
specialized cells but pinocytosis happens for all types of cells. Pinocytic pathways can be 
devided into clathrin mediated endocytosis, caveolae mediated endocytosis, macropinocytosis 
and clathrin/caveolae independent endocytosis. One of the main focus of research in the field 
of cell transfection has been to achieve efficient endosomal escape to avoid degradation of 
nucleic acids in lysosomes. Cationic polymers and liposomes are believed to facilitate the 
endosomal escape utilizing the so-called proton-sponge effect[41]. The proton sponge effect is 
believed to be a result of the large buffering capacity of polycations and cationic lipids inside 
endosomes/lysosomes, which leads to an excessive influx of H+, Cl- and water. This may 
result in osmotic swelling and rupture of the lysosomal membrane and release of the nucleic 
acid into the cytosol[42]. However, this mechanism is still debated and an alternative 
hypothesis explains the cell transfection by polyplexes or lipoplexes through the caveolar 
mechanism that does not involve the endolysosomal pathway[43]. The absence of consensus of 
opinions on such an important aspect as the mechanism of nucleic acid internalization only 
supports the notion that we need more studies to better understand the structure-function 
relation and to identify functionalities critical for the efficient and not toxic artificial gene 
delivery vectors.  
 To avoid the necessity of endosomal escape, various nonendocytic strategies such as 
microinjection, permeabilization and electroporation have been developed. More recently, 
Lee and co-workers[44] reported a modified nonendocytic technique called nanochannel 
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electroporation technique (NEP) for efficient and precise gene and drug delivery without 
damaging the cells.                     
 Combinatorial synthesis and high-throughput screening of lipid-like molecules as well 
as polymer-based libraries are important to understand structure-function relationship, which 
is important for intelligent design of nanocarriers, or to directly identify highly efficient drug- 
and gene-delivery vectors. Combinatorial synthesis and HTS screenings of small molecules or 
polymers have been applied to various challenges in the field of biofunctional materials. Thus, 
Kohn and colleagues developed a combinatorial strategy to synthesize polymeric biomaterials 
using condensation of tyrosine-derived diphenolic monomers and aliphatic diacids[45, 46]. By 
varying the pendant group of the diphenol block and alkyl chain length of diacid block, they 
have synthesized a library of polymers with modulated physical properties and studied 
structure property relationships[47a]. These biocompatible and biodegradable polymers also 
showed potential applications in medical implants[47b]. They also worked extensively on 
combinatorial and computational methods in biomaterials design and the analysis of large 
datasets[47a-d]. Schubert et al. studied approaches for improving the throughput of screenings 
and characterization of various polymer biomaterials including screening of cation polymers 
for gene-delivery[48]. Recently, a number of excellent reviews appeared covering methods for 
combinatorial synthesis and high-throughput screening techniques[49-54]. 
 In this progress report we elaborate on the evolution of high-throughput strategies for 
the synthesis of cationic lipids and polymers for nucleic acid delivery applications. This 
review is organized in the following manner. First, we briefly introduce methods used for the 
parallel high-throughput synthesis of lipid-like molecules and polymers. We then divide the 
synthetic vectors as cationic lipids and cationic polymers while discussing the liposome or 
nanoparticle formation and their applications in nucleic acid delivery. Finally, in the outlook 
we have discussed future challenges and potentials of combinatorial methods for the parallel 
synthesis and screenings of libraries of bioactive molecules and polymers. 
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2. Parallel Lipid and Polymer Synthesis. Synthetic Strategies 
 
Synthetic cationic polymers are considered as promising candidates in the field of 
gene delivery because of a high level of design flexibility and their ability to bind anionic 
nucleic acids and condense them into nanoparticles (polyplexes). Amongst all the polymers 
used in gene delivery, poly-L-lysine (PLL) and polyethyleneimine (PEI) are the most 
thoroughly investigated cationic polymers[55-58,19,30]. However, cytotoxicity and poor gene 
transfer efficiency have limited their applications[59]. Langer and co-workers reported[60] 
parallel synthesis of poly(β-amino esters) (PBAEs) for gene delivery applications. These 
polymers are interesting candidates for gene delivery studies because of their 
biodegradability, low cytotoxicity and easy synthesis by conjugate addition of amines to 
acrylates. In a follow up work, a larger library of 2350 structurally unique PBAEs was created 
using an automated high-throughput combinatorial synthesis [61]. 
The concept of using cationic lipids for gene delivery was first accounted by Felgner 
et al. in 1987 [62]. After that cationic lipids have been widely studied for the past two decades 
as synthetic vectors. Since optimization of each synthetic reaction brings limitations in the 
generation of library of molecules and diversity, many research groups were trying to develop 
very simple synthetic strategies by which one can synthesize a library of synthetic vectors for 
high-throughput screening. Anderson and co-workers generated a library of lipid like 
molecules (lipidoids) using parallel synthesis based on the aza-Michael addition reaction[63] or 
amine-epoxide addition reaction[64]. Using these methods one can generate plethora of 
molecules without any protection and deprotection steps or purification steps. Xu and co-
workers also reported combinatorial libraries based on a similar approach[65]. Hope et al. 
reported a range of ionizable cationic lipids[66]. Recently, we reported a facile parallel 
synthesis of lipidoid libraries using thiol-yne chemistry[67] and alkylation of amines[68]. 
      
  
6 
 
3. Combinatorial Approach to Gene Delivery Nanocarriers based on Polymers 
Cationic polymers have been widely studied as gene-delivery vectors due to their 
polycationic nature and ability to efficiently bind, condense and protect negatively charged 
nucleic acids. Although poly(ethylene imine) (PEI)[69-73], poly lysine (PLL)[74-78] and 
poly(amidoamine) dendrimers (PAMAM)[79-81] are well investigated polymers, their 
cytotoxicity and lack of biodegradability limited their efficiency and clinical applications. 
Later on other degradable polymers such as poly(L-lactide-co-L-lysine)[82-84], poly(4-hydroxy-
L-proline ester)[85,86], poly[R-(4-aminobutyl)-L-glycolic acid][87], were investigated as 
transfection vectors. 
Lynn and Langer introduced a combinatorial synthesis of degradable poly(β-
aminoesters) via Michael addition of diamines to diacrylates[60] (Figure 1). Several polymers 
were synthesized using this method (1a-1c) and the transfection experiments with these 
polymers were carried out using NIH3T3 cell line and luciferase reporter gene (pCMV-Luc). 
Polymers 1a and 1b did not show any transfection activity in initial screening assay, while 
polymer 1c showed transfection efficiency better than that of conventional PEI polymers. 
Polymers 1a-1c and their degradation products were shown to be less cytotoxic to cells in 
comparison to PEI.  
To investigate structure-function relationship, a strategy for the parallel synthesis of 
different poly(β-aminoesters) from di-acrylate esters and bis(secondary amine) was 
developed[88,89]. A library of 140 degradable poly(β-aminoesters) was synthesized from seven 
diacrylate monomers and twenty amine monomers (Figure 1). Out of the 140 members of the 
library, 70 polymers were water soluble and hence they were screened for gene delivery 
efficacy. Many of the polymers were identified as positive “hits” and among them two 
polymers (2a and 2b, Figure 1c) showed transfection efficacy 4-8 fold higher than that of PEI 
and comparable to the efficacy of Lipofectamine 2000 (L2K).  
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The structure-function relationship for these members of the library was investigated. 
It was investigated how the size and surface charge of the nanoparticles composed of 
polymers/DNA affected their ability to mediate cellular uptake, their ability to bypass 
trafficking to lysosomes and finally to enter nuclei for the gene expression. Positively charged 
nanoparticles smaller than 250 nm were found to show highest levels of cellular uptake in 
vitro. Nanoparticles composed of polymers containing imidazole group or two amines in close 
proximity were able to successfully avoid trafficking to lysosomes. 
The combined impact of few important parameters such as molecular weight of 
polymer, polymer end group and polymer/DNA ratio on gene transfection efficiency was 
examined. To investigate these factors two model polymers families (3a and 3b) were 
synthesized by addition of 1,4-butanediol diacrylate or 1,6-hexanediol diacrylate to 4-amino-
1-butanol[90] (Figure 2). By varying diacrylate/amine stoichiometric ratios in each family 
different polymers were synthesized with either amine or acrylate end group and with 
molecular weights ranging from 3350 to 18000 g/mol-1. Transfection efficiency of all 
polymers was examined by varying polymer/DNA ratios ranging from 10:1 w/w to 150:1 
w/w. It was found that all three factors, polymer molecular weight, polymer chain end group 
and polymer/DNA ratio had significant impact on gene transfection efficiency. It was 
observed that polymers terminated with amine monomers were able to deliver DNA to cells 
more efficiently compared to polymers terminated with diacrylate monomers. It was assumed 
that, in case of polymers with amine end group, extra positive charge assisted more efficient 
complexation with DNA. Since these polymers have relatively low amine density, larger 
polymer/DNA weight ratios were required to achieve high level of gene transfection. To 
reduce the amount of PBAEs polymer, small amount of the high amine density polymer poly-
L-lysine (PLL) was incorporated during the polymer/DNA complex formation. The co-
complexing agent PLL indeed enhanced the transfection activity of both polymers 3a and 3b 
(Figure 2). These approaches brought the opportunity to produce several degradable polymers 
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which could easily compete with the best available non-viral vectors for in vitro gene delivery 
applications. 
In 2003, a very large library of 2350 different degradable PBAEs polymers was 
synthesized in a single day using a high-throughput semi-automated methodology[91]. 
Obviously, this is not possible when the traditional “one-structure-per-experiment” is used. In 
addition, all the experiments (synthesis, storage and cell based testing) were performed 
without removing any solvents. All 2350 polymers were screened to examine their capability 
to bind DNA and transfect COS-7 cells (monkey kidney fibroblast cells) and for all polymers 
the N:P ratios were maintained at 10:1, 20:1 and 40:1. Transfection efficiency of the top 50 
polymers from the library was optimized relative to PEI and L2K. Among the best performing 
polymers 46 polymers were found to perform as good as or better than the controls. Out of the 
46 best performing polymers, 26 polymers, possessing either one or two side hydroxy groups, 
were found to perform better than L2K. 
The best performing polymers were refined to a library of 486 polymers for better 
understanding of structure-function relationships[92]. The effects of various possible 
parameters such as polymer molecular weight, polymer end group, polymer/DNA ratio, 
polymer/DNA particle size, particle surface charge and chemical composition on transfection 
were investigated. Highest transfection was achieved by using polymer/DNA ratio of 40:1 or 
higher. In terms of molecular weight, the polymers with molecular weight of 10,000 Da or 
above achieved highest level of transfection. It was noticed that most effective polymers were 
composed of amino alcohol groups together with hydrophobic acrylates. In general, the best 
performing polymers condensed DNA into sub 150 nm particles, while 3 of the top 
performing polymers (4a-c) formed even smaller (71, 79 and 82 nm, respectively) 
nanoparticles. This very small particle size in combination with positive surface charge might 
explain the observed higher transfection efficiency. However, it should be noted that there are 
various factors (e.g. size, charge, lipoplex/polyplex stability, aggregation, membrane 
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fusibility, toxicity, nucleic acid size, delivery into cytoplasm vs. nucleus, etc.) that play an 
important role in transfection efficiency and all these parameters need to be considered 
together when designing novel transfection vectors. Knowledge about the basic structure-
function relationship obtained in these studies might help in designing of superior non-viral 
gene delivery systems. 
Various types of approaches have been undertaken to overcome cytotoxicity 
limitations in delivery applications. Polyethylene glycol (PEG) has several advantages as, for 
example, it is hydrophilic, biocompatible, increases blood circulation time, reduces plasma 
clearance and prevents protein opsonization. Keeping these features in mind, Cho and co-
workers[93] have synthesized and screened a mini library of poly(β-amino esters) (PBAEs) 
composed of γ-aminopropyl triethoxysilane (APES) and poly(ethylene glycol)diacrylate 
(PEGDA) (Figure 3a) using combinatorial chemistry and high-throughput screening 
technique. Their transfection efficiency and toxicity were examined using 293T and HeLa 
cells in the presence and absence of serum (Figure 3b). It was observed that transfection 
efficiency and cell viability of these polymers are very sensitive to monomers ratio not on 
PAE/DNA weight ratio. The PBAE, where stoichiometric mole ratio of APES to PEGDA was 
maintained at 6:1, was found to show excellent cell viability and high level transfection 
efficiency in 293T and HeLa cells. 
Facile incorporation of diverse functional groups into polymers with well defined 
architectures is another promising approach towards libraries of structurally distinct polymers. 
Keeping this in mind, a series of different block copolymers consisting of a methacrylate 
backbone, epoxide and oligo-ethylene oxide side chains were synthesized [94]. Utilizing high-
throughput robotic technique, sixteen copolymers were reacted with ninety six different types 
of amines to form a large library of 1536 structurally distinct core-shell nanoparticles with 
cationic cores and variable shells (Figure 4). These polymers were tested with siRNA and 
pDNA for their performances both in vitro and in vivo experiments. It was observed that the 
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amines with more protonizable nitrogen showed better complexation with nucleic acids. In 
case of nanoparticles with anionic shell, the nucleic acids were unable to complex with the 
shell of the nanoparticles, but were able to complex with the core of the nanoparticle. The 
effect of amine structure on cellular internalization was also examined. It was noticed that 
tertiary amine containing nanoparticles were internalized more efficiently compared to 
secondary amines. On the other hand, nanoparticles with pyrrolidine and piperazine showed 
better internalization as compared to morpholine and imidazole group. In general, presence of 
the tertiary amine group in a nanoparticle increased the efficiency of complexation, delivery, 
cellular internalization and siRNA silencing. Best performing nanoparticles were tested for in 
vivo siRNA delivery by using the mouse Factor VII gene silencing model and showed ~40% 
silencing of factor VII. 
Combinatorial chemistry offers the privilege to generate a multitude of new functional 
materials from a very few simple precursor molecules. Thus, applying combinatorial 
chemistry, a small library of functionalized polyacrylic acids (PAA) was prepared and their 
structure-function relationship towards siRNA delivery was investigated[95]. This library was 
generated by the side chain substitution of PAA with two different molecules, agmatine 
(Agm) and D-(+)-galactosamine (Gal), at varying ratios (Figure 5). All the polymeric vectors 
were complexed with siRNA and screened for siRNA delivery and protein knockdown using 
MDA-MB-231-luc+ cells. Polymeric vector with a polymer precursor Mn of 5 kDa and 10 
kDa showed better knockdown efficiency. Amongst them, polymer vector with 5 kDa PAA 
backbone with a side chain composition of 55% Agm and 17% Gal achieved the highest 
protein knockdown of 84%. This study suggested that a critical balance between Agm/Gal 
content and polymer molecular weight was essential to accomplish a good knockdown 
efficiency. 
Amiji and co-workers have developed a strategy for the synthesis of combinatorial 
library of dextran based lipid derivatives using click chemistry as a synthetic tool. In aqueous 
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medium, the lipid derivatives self-assembled into nanostructures which showed encapsulation 
of diverse anticancer therapeutics[96]. In addition to small molecule delivery, they have also 
shown delivery of siRNA using the lipid derivatives[97]. Doxorubicin (DOX) and siRNA were 
separately loaded into the dextran based nanoparticle. The results showed significant 
knockdown of the P-glycoprotein level in drug resistant osteosarcoma cells, while the DOX 
loaded dextran nanoparticles showed efficient antiproliferative activity[97].  
Hyaluronic acid (HA), a natural polysaccharide, has also been used to generate 
combinatorial polymeric libraries for drug as well as gene delivery applications[98]. HA has 
been widely used in the delivery applications because of its important property to bind CD44 
receptors present on the surface of metastatic cells[99]. Amiji and co-workers developed[100] a 
very simple strategy to synthesize a library of amine derivatives of HA using NHS/EDC 
coupling chemistry. HA backbone was functionalized with various primary amines and 
polyamines (PEI and poly-L-lysine). The siRNA was complexed with PEG-based HA and 
amine derivatives of HA to form functionalized nanoparticles. Initial screening of the library 
using human lung cancer cells suggested that HA nanoparticles were able to deliver siRNA 
into the cells overexpressing CD44 receptors. Two formulations, HA-PEI and HA-PEG 
showed ~55% gene silencing.  
In a follow up work,[101] they have studied combination therapy of an anticancer drug 
cisplatin and HA loaded siRNA against survivin, bcl-2, mdr1 and mrp1 genes. Experiment in 
cisplatin-resistant A549 cells against survivin and bcl-2 genes showed ~80% cell death. 
Cisplatin sequestered HA nanoparticles were examined  in vivo in A549DDP  xenograft tumor 
bearing mice. The combination therapy resulted in ~62% suppression in tumor growth with 
no side effect and toxicity[102]. In addition, preferential accumulation of the particles in CD44 
high-expressing A549 and A549DDP cells in comparison to the low CD44 expressing H69 and 
H69AR cells was shown. 
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4. Combinatorial Approach to Cationic Lipidoid/Peptoid-based Nanocarriers for Gene 
Delivery 
Most of conventional lipids are synthesized via multi-step methods, involving various 
chemical protection-deprotection, purification and individual optimization[103], which limits 
the ability to perform parallel high-throughput synthesis of large lipid libraries. To address 
these problems, novel facile and efficient methods ideally not requiring extensive purification 
procedures are required.  
Lipid-based gene delivery systems have some advantageous compared to viral vectors 
based approaches because there is lower risk of immunogenicity and no infection risks. 
Although the transfection efficiency of cationic lipid based systems is still often poor 
compared to the viral gene transfer, superior safety profile and ease of synthesis have made 
cationic lipids potential synthetic vectors for gene delivery in vivo. Transfection efficiency is 
predominantly dependent on the biophysical properties of the cationic lipid aggregates 
(liposomes and lipoplexes), which is related to the structure of the cationic lipids, buffer, 
composition, pH and the liposome manufacturing method. A small alteration in the structure 
might affect the aggregation properties, size, z-potential of liposomes and transfection 
efficiencies. Combinatorial chemistry and high-throughput screening technique have brought 
the opportunity to rapidly screen and investigate the structure-function relationship in lipid-
based gene delivery systems.  
Thus, a library of new cationic lipids based on 3-methylamino-1,2-dihydroxypropane as 
the polar, cationic lipid part and different hydrocarbon chains as the nonpolar lipid part, was 
generated using combinatorial solid phase chemistry[104]. The lipid N,N-ditetradecyl-N-
methyl-amino-2,3-propanediol (KL-1-14) from the combinatorial library was identified as the 
best performing transfection vector (Figure 6). Further, the counter ion also had an effect on 
the transfection efficiency and chloride ion led to the best performance. Accordingly, the best 
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performing lipid, KL-1-14 had shown the transfection efficiency to be 1.3-8 times higher than 
that of DOTAP. 
Anderson and co-workers reported[63,105] a synthetic method to generate a large library of 
over 1200 structurally diverse lipidoids (Figure 7). Lipidoids were synthesized by the 
conjugate addition of alkyl acrylates or alkyl acrylamides to primary or secondary amines. 
First, a library of 700 lipidoids was synthesized, screened for the ability to deliver siRNA to 
the HeLa cell line. The most effective materials were found to contain more than two amines 
per head unit, two long or short amide tails. Based on this data, second generation library of 
over 500 lipidoids was synthesized and screened with HeLa cells (Figure 7b,c). Fifty six 
lipidoids were identified as top performing lipidoids which induced gene silencing at levels 
similar to that of L2K. Few common features of these top performing materials suggest design 
criteria for making future transfection vectors. These common features are i) amide groups; ii) 
more than two alkyl tails; iii) tail length in the range of more than 8-12 carbons and iv) a 
secondary amine present in the structure. Seventeen top performing lipidoids, identified from 
the in vitro screen were tested for the in vivo systemic delivery of siRNA to mouse liver.  
As a follow up study, a refined combinatorial library of lipidoids was synthesized through 
the conjugate addition of different amines to a sublibrary of acrylamides[106]. Nanoparticles 
from these lipidoids were made to facilitate non-viral delivery of siRNA to the endothelial 
cells (ECs). All lipidoids were screened and two (114N9-5 and 110N9-5) (Figure 8b,c) were 
found to increase human umbilical vein endothelial cells (HUVECs) viability significantly. 
The identified optimal lipidoids were used to transfect therapeutic siRNA (siSHP-1) into ECs 
and down regulate the target Src-homology 2 domain-containing protein tyrosine 
phosphatase-1 (SHP-1). They showed SHP-1 silencing significantly greater (p<0.01) than 
L2K in the presence of serum and silencing of SHP-1 expression considerably increased EC 
proliferation and decreased EC apoptosis under a simulated ischemic condition. 
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Lipidoids have been also developed for low dose in vivo gene silencing. The low-dose 
delivery is interesting because of the requirement of very small amount of carrier materials to 
transport the nucleic acid to its target locations. To identify an optimal delivery vehicle a 
library of 126 lipidoids was built[64] using the epoxide chemistry. The library was created 
through the ring opening of epoxide by amine substrates and the reaction products were used 
in cell based screens without any purification. The library was screened using luciferase 
expressing HeLa cells and anti-firefly luciferase siRNA. It was found that to impart delivery 
activity it is important to maintain the optimized combination of amine and tail length of the 
hydrophobic tail. In general, the top performing lipidoids were found to contain N-(2-
aminoethyl)-N-methylethane-1,2-diamine as a head group and fourteen or more carbons in the 
hydrophobic tail. Three lipidoids were identified to show more than 70% silencing at a siRNA 
dose of as low as 5 ng per well. The top performing lipidoids from the initial screening were 
evaluated for in vivo performance using mouse Factor VII gene silencing model. To stabilize 
the complex in serum, distearoyl phosphatidylcholine (DSPC), cholesterol and polyethylene 
glycol (PEG) were used at a particular ratio in the formulation. The nanoparticle diameter was 
in the range of 65 to 250 nm. One compound (C12-200) in particular showed very high 
silencing efficiency. 
Xu with colleagues utilized the epoxide-amine addition reaction to synthesize a library of 
lipidoids with ternary amine head groups[107]. They then alkylated amines in the head group 
with methyl iodide to form a library of quaternized lipidoids (QLD). The QLDs alone showed 
low efficiency for DNA delivery. By formulating liposomes with a neutral helper lipid, such 
as 1,2-dioleoyl-sn-glycero-3-phosphoethanolemine (DOPE), the capability of QLDs for gene 
transfection was significantly enhanced. 
Combinatorial approach has been utilized to determine the effect of lipidoid functional 
groups on siRNA delivery performance[108]. In order to get more insight into the structure-
property relationship of two promising siRNA delivery candidates, a library was generated by 
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using those two candidates as core lipidoid starting materials. To synthesize the library, 
hydroxyl, carbamate, ether, or amine functional groups containing acrylamides or acrylates 
were added to the core lipidoids. The alkyl chain length and branching were also varied in 
order to incorporate more diversity into the structure. The impact of the functional group was 
found to vary depending on the overall amine content and number of tails. The in vitro 
screening of the library was carried out using luciferase reporter system in HeLa cells. The in 
vivo studies were performed using a Factor VII knockdown assay. Two members were 
identified to show protein knockdown efficiency comparable with those of the parent core 
lipidoids. Surprisingly, both of the highest performing members were found to contain an 
ether functional group. This study educated us about the fact that a small structural change 
can affect the knockdown efficiency and cell viability both in vitro and in vivo.  
A combinatorial approach has been also used to design and construct a library of 
structurally diverse lipidoids to study the effect of unsaturated tails of lipidoids on gene 
transfection efficiency[109]. Simple Michael addition of different amines to oleyl acrylamides 
(one with saturated tail and another with unsaturated tail) was used to synthesize all the 
members of the library. The lipidoids were complexed with DNA or mRNA (Figure 9a,b) and 
their capability in transfecting HeLa cells was evaluated by counting GFP-positive cells after 
DNA or mRNA delivery. The analysis of structure-activity relationship of lipidoids revealed 
that the introduction of unsaturation in the hydrophobic tail could enhance the transfection 
efficiency of lipidoids (Figure 9c). The increased transfection efficiency is apparently due to 
the increased cellular uptake and enhanced intracellular nucleic acid release from the 
nanocarriers composed of unsaturated lipidoids. 
Michael addition reaction of amines and alkyl-acrylate or alkyl-acrylamide was utilized 
to create a small library of 36 lipidoids[110]. They were utilized to test the possibility of using 
binary combination of lipidoids to synergistically achieve gene silencing. From the 
microscopy experiment it was found that synergistic effect resulted when both materials in the 
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binary combination took part individually in two important steps in the delivery process, 
cellular uptake and endosomal escape. Some of the binary combinations showed high levels 
of gene silencing both in vitro and in vivo. This binary approach might increase the material 
space available for therapeutic development. 
In another study, aminoglycosides, a class of antibiotics,[111,112] were modified with 
hydrophobic lipid tails and used in siRNA delivery applications. The multiple amino groups 
in the aminoglycoside structure were used as attachment points for hydrophobic lipid tails. A 
library of lipid modified aminoglycosides was prepared by a single step reaction of epoxides 
with commercially available aminoglycosides[113] (Figure 10). The lipid modified 
aminoglycosides were screened using luciferase reporter system in HeLa cells. The length of 
lipid tails and the core scaffold of aminoglycosides both were found to be essential for 
achieving maximal efficacy. It was noticed that geometric and topological features of these 
materials were crucial for their transfection performance. 
Recently, we introduced a novel method to synthesize libraries of cationic thioether lipids 
possessing a linker group structurally mimicking the glycerol core of the phospholipids[67]. 
The thioether lipids were synthesized using the thiol-yne click chemistry followed by acid-
amine coupling reaction. The structure-activity relationship and the effect of size and surface 
charge of the liposomes on the transfection efficiency were analyzed. An unsaturated neutral 
phospholipid, phosphatidylethanolamine (DOPE) was used as a helper lipid during the 
formulation of lipoplexes. In vitro screening was carried out using HEK293T cells and L2K 
was used as a positive control. Almost 10% of the lipids were found to show efficiencies 
significantly higher than that of L2K. The length of the hydrophobic tail had a striking effect 
on cell transfection. The hydrophobic tails C11 and C12 were found to show enhanced 
transfection efficiency than shorter chains (Figure 12). In addition to the structural 
requirement, particle size and surface charge were also shown to be very important 
parameters to achieve efficient gene delivery. The initial screening suggested 100-200 nm as 
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optimal size and 60-70 mV as optimal z-potential of liposomes. This methodology resulted in 
the development of a series of novel transfection reagents, ScreenFect®, competing with the 
Lipofectamine reagents. Similar approach based on the thiol-yne click reaction was utilized 
by Alabi et al. in the synthesis of cationic lipids with multiple hydrophobic tails[114]. A library 
of 32 lipidoids was synthesized and its performance for siRNA transfection was investigated 
both in vitro and in vivo. 
In another study, simple alkylation of amines with alkyl halides could be used to generate 
a library of approx. 500 lipid-like molecules capable of cell transfection[68]. Both the length of 
hydrophobic tails and the nature of cationic head groups were found as important parameters 
in transfection efficiency. The lipidoids containing either 1-(2-aminoethyl) pyrrolidine or 3-
(dimethylamino)-1-propylamine head group and C16 or C18 hydrophobic chains, showed 
maximum activity. Dimethylamine head group used previously in lipidoids[67] or polymers[115] 
also showed remarkable performance in cell transfection. The small particle size and high 
positive surface charge are two important parameters to maintain high transfection efficiency 
in vitro. Lipidoids with only one hydrophobic tail did not show appreciable transfection 
efficiency and this might be due to the formation of bigger and less stable particles. 
Interestingly, a binary mixture of single tailed (1C16-S) and double tailed (1C16-D) lipidoids 
showed enhanced transfection efficiency (Figure 13). This could be attributed to the fact that 
single tailed and double tailed lipidoids played different roles in the lipoplex formation. The 
single-tailed lipid increased surface charge of the liposomes and lipoplexes, while the double-
tailed lipid formed smaller and more stable lipoplexes. 
Xu and co-workers generated a combinatorial library of lipidoids for in vitro delivery of 
DNA[65]. The lipidoids were formed by using mild reaction of amines with acrylates, 
acrylamides or epoxides. All the members in the library were tested for their ability to deliver 
β-gal DNA to HeLa cells. They efficiently self-assembled with DNA through electrostatic 
interaction and formed condensed multilamellar structured nanocomplexes. Some of them 
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formed loose spaghetti and meatball-like structures[116] (Figure 14b-d). Initial screen 
suggested that the lipidoids with amide linkage were more efficient compared to the lipidoids 
with ester or hydroxyl groups. The amine head group and hydrophobic tail length also had 
effect on the delivery efficiency.  From the initial screen, three top performing lipidoids (14O-
87, 14N-87 and 16C-87) were identified (Figure 14a). Among the three lipidoids, 14N-87 
showed the highest transfection efficiency, which could be attributed to its higher efficiency 
in multilamellar nanoparticle formation compared with the other two lipids.  
Hope and co-workers reported[117] that cationic lipid molecules with permanently charged 
hydrophilic head groups were less efficient in gene knockdown in vivo as compared to 
ionizable lipids. They reported detailed investigation of the role of ionizable amine head 
group in the delivery of nucleic acid in vivo. A highly potent cationic lipid 2,2-dilinoleyl-4-
dimethylaminoethyl-[1,3]-dioxolane (DLin-KC2-DMA) (Figure 15a) was selected as a core 
lipid and the hydrophilic head-group region was extensively modified to generate a library of 
56 novel amino lipids with different pKa values ranging from 4.12 to 8.12. All 56 amino 
lipids were screened and the corresponding plot of pKa versus ED50 (median effective dose for 
FVII gene silencing in female C57BL/6 mice by intravenous administration) suggested a 
steady correlation between the in vivo activity and pKa of amine head group. The optimum 
pKa was found to be 6.2-6.5 and on either side the potency of lipid nanoparticles rapidly 
decreased. Interestingly, lipids with similar pKa values were found to show very different 
potency value. This suggested that optimal pKa value is not the only necessary condition to 
create an efficient delivery vector in vivo. Other structural parameters such as hydrophobic 
tails, linker between head group and tail also provided substantial contribution. It is notable 
that one of the most active cationic lipid, DLin-MC3-DMA [dilinoleylmethyl-4-
dimethylaminobutyrate (16, ED50=0.03 mgkg-1, pKa=6.44)] (Figure 15b) is currently in 
clinical trials for treating hypercholesterolemia. 
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In a follow up work, the authors synthesized[118] a few lipids which were structurally 
similar to DLin-MC3-DMA. The ester linkage was incorporated into the hydrocarbon chain 
region of the amino lipid in order to achieve biodegradability. The ester linkage can be 
enzymatically cleaved by esterase or lipase activity present in the tissue or intracellular 
compartment[119,120]. The negatively charged carboxylate generated from the hydrolysis can 
accelerate the release of siRNA from the carrier[121]. The lipid evaluated in this study 
exhibited biodegradability, rapid elimination from the plasma and tissue, substantial 
tolerability and excellent potency in rodents. The compound L319 (Figure 15c) was 
designated as the best lipid. To the best of our knowledge, this was the first demonstration of 
a biodegradable lipid with efficacy profile comparable to the advanced lipids currently 
available for siRNA delivery. 
Bioreducible lipid nanoparticles have been used to enhance the intracellular siRNA 
delivery. The transfection vector complexed with siRNA, escorts them to cytosol in the form 
of a nanoparticle and releases them into the cytosol. If the binding between siRNA and carrier 
is very strong then releasing them in the cytosol might be difficult. Keeping that in mind, Xu 
and co-workers[122] designed bioreducible lipidoids integrating disulfide bond, which can act 
as a “smart” siRNA delivery vehicle and can easily release the siRNA in response to 
intracellular redox environment. Using the Michael addition reaction of amines and acrylates 
they synthesized six bioreducible lipidoids and six non-bioreducible lipidoids as a control set 
of lipidoids. The results suggested that the nanocarriers made of bioreducible lipidoids 
released siRNA more efficiently than the nonbioreducible lipidoids under a reductive 
intracellular environment. Among all the lipidoids, the lipidoid 1-O16B was found to show 
the highest efficiency at N/P ratio 5 (Figure 16). The highest performing lipidoid, 1-O16B 
was used to deliver siRNA-targeting GFP to suppress GFP expression of MDA-MB-231 cells, 
targeting Plk-1 into cancer cells to interfere with cell progression and prevent tumor cell 
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proliferation. This approach provides valuable information about structure-functionality 
relationships of lipid based siRNA systems. 
Montenegro et al. reported a library of 702 cationic lipidoids where the charged head 
groups were connected with hydrophobic tails via hydrazones, oximes or disulfide bridges 
making these lipidoids redox or pH responsive[123]. 
Zuckermann and co-workers[124] reported a combinatorial library of N-substituted glycine 
oligomers called peptoids, in which cationic and non cationic side chains were distributed in a 
specific pattern. Variation of length, density of charge, side-chain shape and hydrophobicity 
introduced diversity into the structure of the peptoids. Peptoids were used to condense DNA 
into a nanoparticle (diameter ~50-100nm) and transfect into specific cells. Nanoparticle 
formation and transfection activity were found to be highly dependent on the primary 
sequence of the peptoids and to a lesser extent, on the length of the peptoid. Screening of the 
library revealed the 36-mer peptoid with 12 cationic aminoethyl side chains as a most active 
peptoid. The most active peptoid was found to show transfection efficiency greater than or 
comparable to DMRIE-C, Lipofectine and Lipofectamine. The reason behind the behavior of 
the most active peptoid was not very clear, but in the electron microscopy studies, most active 
peptoids showed regular structure with DNA, whereas inactive peptoids were found to show a 
less ordered structure. The ordered structure suggested a specific interaction of the peptoid 
with the DNA, which might help in effective complexation and efficient transfection.  
 
5. Summary and Outlook  
Nanoparticles based on cationic polymers, lipids or lipidoids are of great interest in the 
field of gene delivery applications. The research on these nanosystems is rapidly growing as 
they hold promise to treat wide variety of human diseases ranging from viral infections to 
genetic disorders and cancer. Nanocarriers protecting nucleic acids and enabling their delivery 
into the right tissue and cell type both in vitro or in vivo are crucial for the development of 
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future highly efficient synthetic gene delivery vectors. However, self-assembly of amphiphilic 
cationic molecules or polymers in water and in the presence of nucleic acids into 
nanoparticles is a highly complex process where a multitude of factors influence the final 
physical, chemical and biological properties of the produced nanocarriers. “Intelligent design” 
of such nanoarchitectures is currently still very difficult. Thus, high-throughput parallel 
generation and screening of large libraries of such nanocarriers is a very efficient and 
powerful way to identify efficient and non-toxic gene delivery vectors. In addition, 
understanding of initial structure-function relationships resulting from the high-throughput 
screening of hundreds to thousands of structurally diverse lipids or polymers will eventually 
help to develop novel principles for more “intelligent” design of nanoarchitectonics and gene 
delivery systems in the future. 
In vivo applications of gene-delivery systems is a challenging but very important goal that 
combinatorial chemistry is yet to achieve. The main difficulty of in vivo vs. in vitro 
applications is that most of cationic liposomal or polymer-based vectors are highly toxic 
and/or completely inefficient in vivo. Therefore, search for in vivo vectors and combinatorial 
synthetic strategies should rely on partly different design principles. Examples of such 
parameters might include (but not limited to) introduction of PEG functional groups, reducing 
or even reversing the charge of the polar head groups, using zwitterionic functionalities, 
achieving multilayered structures or using functional groups for ensuring active targeting, or 
introducing unsaturated hydrophobic tails, etc. 
Other future challenges that need to be addressed include purity of the produced lipidoids 
or polymers. It is usually difficult to make a parallel combinatorial synthesis of thousands of 
molecules compatible with efficient purification, e.g. chromatography. However, precipitation 
or extraction, most commonly used for parallel purification, do not always give satisfactory 
purity of the chemicals. Reproducibility of polymer molecular weights and polydispersity is 
another often overlooked or neglected problem. Identification of an efficient lipid or a 
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polymer does not necessarily mean that this lipid or polymer will have the same efficiency 
after scaling up the synthesis. Liposome or polymersome preparation is another challenge. 
Preparation of liposomes in a thousand of 500 µL vials or a round-bottom 1 L flask will 
definitely require different methods leading to different liposomal properties (e.g. size, 
stability, charge) and, therefore, transfection performance. All these aspects need to be 
considered when designing new combinatorial methods for parallel synthesis of future gene-
delivery vectors. 
Nevertheless, the ability to rapidly screen thousands of parameters, chemical, physical or 
biological, can dramatically increase the discovery rate. Finally, the same approach based on 
parallel high-throughput synthesis of structurally diverse chemical libraries can also be 
applied to other biofunctional systems and biological problems, for example, for the 
development of nanoarchitectonics and nanoparticles for drug delivery applications, “smart” 
stimuli-responsive materials or multi-functional nanoparticles for theranostic applications. 
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Table 1: Polymer and lipid based materials produced through combinatorial synthesis for 
gene delivery applications 
Polymer/ 
lipidoid 
Details Nucleic 
acid 
Cell type Assay Ref. 
Polymers Poly(-amino esters) (PBAEs) siRNA NIH3T3, COS7, 
etc.  
in vitro 60, 61, 
88, 89 
Polymers PBAEs with pendant hydroxyl groups, 
complexed with PLL 
pDNA COS7, NIH3T3, 
CHO, HepG2 
in vitro 90 
Polymers PBAE with pendant silane groups and 
backbones incorporating PEG 
pDNA HEK293T, 
HeLa 
in vitro 93 
Polymers 1536 polymer nanoparticles based on 
polymethacrylate block-copolymers with 
pendant epoxy groups cross-linked with 
diamines 
pDNA, 
siRNA 
HeLa, liver 
hepatocytes in 
mice 
in vivo, 
in vitro 
94 
Polymers Poly(acrylic acid) (PAA) modified with 
galactosamine and agmatine 
siRNA MDA-MB-231-
luc+ 
in vitro 95 
Polymers Epoxide-amine addition siRNA HeLa, C57BL/6 
mice 
in vitro, 
in vivo 
64 
Polymers Dextrans modified with lipid, thiol or 
PEG via click reaction 
drugs, 
siRNA 
SKOV3 in vitro 96, 97 
Lipidoids Solid phase synthesis of lipidoid library 
with alkyl tails of different length and 
different counter ions 
pDNA MDA-MB-468, 
MCF-7, 
MDCK-C7, 
COS-7, KL-1-
14 
in vitro 104 
Lipidoids Michael addition of acrylates or 
acrylamides to amines 
siRNA HeLa, HUVEC, 
HepG2, 
macrophages, 
mice, rats, 
monkeys 
in vitro, 
in vivo 
63, 105, 
106 
Lipidoids Michael addition of acrylamides to 
amines. Comparison of saturated vs. 
unsaturated lipid tails 
mRNA, 
pDNA 
HeLa, MCF-7, 
HepG2, MDA-
MB-231, NIH-
3T3, BJ 
in vitro 109 
Lipidoids Lipidoids via thiol-yne photo-click 
reaction 
pDNA, 
siRNA 
HEK293T, 
HeLa 
 
in vitro 67 
Lipidoids Single- and two-tailed lipidoids via 
alkylation of amines 
pDNA HEK in vitro 68 
Lipidoids Acrylate-amine Michael addition to form 
lipidoids with reducible disulfide bonds 
in the lipidoid tail 
siRNA MDA-MB-231, 
HeLa, 4T1 
in vitro 122 
Lipidoids 56 amino lipids with unsaturated linoleyl 
tails based on DLin-KC2-DMA and with 
different pKa values 
siRNA C57BL/6 mice in vivo 117, 118 
Lipidoids Combination of the thiol-yne and amine-
acrylate Michael addition reactions 
siRNA C57BL/6 mice, 
HeLa 
in vitro, 
in vivo 
114 
Lipidoids Quaternized lipidoids synthesized by 
epoxide-amine addition, followed by 
quaternization 
pDNA HeLa in vitro 107 
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Figure 1. a) Representative synthetic scheme of polymer PBAEs; b) Chemical structure of 
acrylates and amines used to generate the library; c) Structure of polymer 2a and 2b; d) 
Transfection data; the right column (marked *) displays values for the following control 
experiments: no polymer (green), PEI (red), and Lipofectamine 2000 (light blue). Reproduced with 
permission (d). [88] Copyright 2001, American Chemical Society. 
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Figure 2. a) Chemical structure of best performing polymers 3a and 3b; b) 
Enhancement of transfection activity of 3a (Poly-1) and 3b (Poly-2) based delivery 
vectors through the use of PLL as a co-complexing agent. b) 3b, amine-terminated 
chains, Mw =13400 blended with different amounts of PLL. Typical standard 
deviation = 20%. Reproduced with permission (b and c).[90] Copyright 2003, 
American Chemical Society.  
  
Figure 3. a) Chemical structure of the PAE co-polymer; b) Transfection efficiency of 
PAE/DNA complexes in serum free-media at various mass ratios in 293T cells. 
Reproduced with permission (b).[93] Copyright 2008, Springer.   
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Figure 4. Synthesis occurs via the ring-opening reaction of epoxides by amines forming 
β-hydroxyl groups and crosslinking points separated by the functionality (X) contained in 
the amine.  
 
 
Figure 5. Chemical structure of the functionalized poly(acrylic acid) (PAA)  
 
 
Figure 6. Top: Chemical structure of N,N-dialkyl-N-methyl-amino-2,3-propanediol 
with alkyl groups of different length; Bottom: library of the same lipid; Chloride, 
sulfate, methyl sulfate and acetate were used as a counter ion.    
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Figure 7. a) Representative general chemical structure of the lipidoids studied; b) In 
vitro screening of lipidoids for siRNA delivery; The average percent reduction in firefly 
luciferase activity after treatment with siRNA-lipidoid complexes at a 5:1 (wt/wt) ratio in 
quadruplicate is shown. For ease of analysis, data are grouped as follows: no test, 0–20% 
knockdown, 20–40%, 40–60%, 60–80%, 80–100%; c) Optimized in vitro knockdown by 
lipidoids in HeLa cells. Reproduced with permission (b and c).[63] Copyright 2008, 
Nature Publishing Group.   
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Figure 9. TEM images of a) the complex of saturated tail containing lipidoid and DNA 
and b) the complex of unsaturated tail containing lipidoid and mRNA; c) Initial in vitro 
screening results of lipidoid efficiency at delivering EGFP encoding (c) DNA and (d) 
mRNA into HeLa cells. Reproduced with permission.[109] Copyright 2012, American 
Chemical Society.  
 
 
Figure 8. a) Representative chemical structure of one member of 98N12 (best 
performing lipidoid) series; b) and c) Representative chemical structure of 114N9-5 and 
110N9-5 lipidoids.  
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Figure 10. a) Representative structures of aminoglycosides. A schematic reaction between 
aminoglycosides and epoxides is shown with 2 deoxystreptamine; b) A scheme of 
nanoparticle formulation; c) TEM) images obtained for formulated nanoparticles to show 
the core-shell morphology; d) Particle size distribution as measured by dynamic light 
scattering (DLS). Reproduced with permission.[113] Copyright 2013, WILEY-VCH Verlag 
GmbH & Co. KGaA, Weinheim. 
 
Figure 11. a) Representative chemical structure of best performing lipidoid 304O13; b) A 
cryo TEM image of lipidoid nanoparticles. Scale bar 100 nm. c) A schematic presentation 
of lipoplex/nanoparticle formation. Reproduced with permission.[105] Copyright 2014, 
Nature Publishing Group.  
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Figure 12. a) Chemical structure of a representative member of the library; b) Graph 
showing relative transfection efficiency of 112 lipids from the library. c) Examples of 
fluorescent microscopy images of HEK293T cells transfected with different lipids from 
the library. Images show nuclei stained with the DNA dye Hoechst (upper row, showing 
total cell number) and GFP positive cells (bottom row, transfected cells). L2K and 
Promofectin were used as positive controls. Reproduced with permission.[67] Copyright 
2012, Royal Society of Chemistry.  
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Figure 14. a) Chemical structure of three top performing lipidoids. TEM images of b) 
14N-87/DNA complex; c) 16C-87/DNA complex; d) 14O-87/complex. e) Relationship of 
positive to negative charge (P/N) ratios of lipidoids/DNA and DNA delivery efficiency. 
Reproduced with permission.[117] Copyright 2012, American Chemical Society. 
 
 
Figure 13. a) Chemical structure of 1C16-D and 1C16-S; b) Synergistic effect of the 
combination of lipidoids with single (1C16-S) and double (1C16-D) hydrophobic tails on 
cell transfection efficiency; Ratios shown below graph indicate 1C16-S/1C16-D. L2K = 
lipofectamine 2000. Reproduced with permission.[68] Copyright 2013, American Chemical 
Society.   
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Figure 16. a) Chemical structure of best performing lipidoid; b) GFP expression of 
GFP-MDA-MB-231 cells treated with naked siGFP, lipidoid/siGFP nanocomplexes, 
and L2K/siGFP complexes; Data are presented as mean ± SD ( n = 3, the two asterisks 
refer to statistical significance between bioreducible and nonbioreducible lipidoid 
facilitated siRNA delivery, P < 0.05, Student’s t -test). Reproduced with 
permission.[122] Copyright 2014, WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim.    
 
 
Figure 15. Chemical structure of a) Dlin-KC2-DMA; b) Dlin-MC3-DMA; and c) L319 
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